APA (7th ed.) Citation

Benedetti, L., Ferrari, L., Ruggiero, A., Braccialarghe, N., Piermatteo, L., Sarmati, L., . . . Iannetta, M. (2024). SC-45 Comparing T-Spot and in-house IGRA for assessing SARS-CoV-2-specific cell-mediated immunity. Sexually transmitted infections, 100(Suppl 1), A115-A116. https://doi.org/10.1136/sextrans-ICAR-2024.105

Chicago Style (17th ed.) Citation

Benedetti, L., L. Ferrari, A. Ruggiero, N. Braccialarghe, L. Piermatteo, L. Sarmati, AM Geretti, and M. Iannetta. "SC-45 Comparing T-Spot and In-house IGRA for Assessing SARS-CoV-2-specific Cell-mediated Immunity." Sexually Transmitted Infections 100, no. Suppl 1 (2024): A115-A116. https://doi.org/10.1136/sextrans-ICAR-2024.105.

MLA (9th ed.) Citation

Benedetti, L., et al. "SC-45 Comparing T-Spot and In-house IGRA for Assessing SARS-CoV-2-specific Cell-mediated Immunity." Sexually Transmitted Infections, vol. 100, no. Suppl 1, 2024, pp. A115-A116, https://doi.org/10.1136/sextrans-ICAR-2024.105.